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Abstract
Bats in the northeastern U.S. are affected by geomycosis caused by the fungus Geomyces destructans (Gd). This infection is
commonly referred to as White Nose Syndrome (WNS). Over a million hibernating bats have died since the fungus was first
discovered in 2006 in a cave near Albany, New York. A population viability analysis conducted on little brown bats (Myotis
lucifugus), one of six bat species infected with Gd, suggests regional extinction of this species within 20 years. The fungus Gd
is a psychrophile (‘‘cold loving’’), but nothing is known about how it thrives at low temperatures and what pathogenic
attributes allow it to infect bats. This study aimed to determine if currently available antifungal drugs and biocides are
effective against Gd. We tested five Gd strains for their susceptibility to antifungal drugs and high-throughput screened
(HTS) one representative strain with SpectrumPlus compound library containing 1,920 compounds. The results indicated
that Gd is susceptible to a number of antifungal drugs at concentrations similar to the susceptibility range of human
pathogenic fungi. Strains of Gd were susceptible to amphotericin B, fluconazole, itraconazole, ketoconazole and
voriconazole. In contrast, very high MICs (minimum inhibitory concentrations) of flucytosine and echinocandins were
needed for growth inhibition, which were suggestive of fungal resistance to these drugs. Of the1,920 compounds in the
library, a few caused 50% - to greater than 90% inhibition of Gd growth. A number of azole antifungals, a fungicide, and
some biocides caused prominent growth inhibition. Our results could provide a theoretical basis for future strategies aimed
at the rehabilitation of most affected bat species and for decontamination of Gd in the cave environment.
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Introduction
Geomyces destructans (Gd) causes geomycosis, a devastating disease
of hibernating bats that has resulted in the death of tens of
thousands if not more than a million individuals of six bat species
in the northeastern U.S. The fungus is the only etiologic agent thus
far identified that is associated with White Nose Syndrome (WNS)
[1,2]. To date, Gd has most seriously affected an insectivorous
species, Myotis lucifugus (‘‘little brown bat’’), but recent studies
indicate that it causes high mortality in other bat species and in
geographical areas beyond the northeastern U.S. [3]. The
projected regional extinction of M. lucifugus could lead to a serious
imbalance in the ecosystem with unforeseen consequences [3].
There is an urgent need to understand the pathogenesis of
geomycosis and to devise control measures to halt and reverse this
potential mass extinction.
Any scheme for the treatment of infected bats with antifungal
drugs faces a number of challenges. At the outset, there is no
information about the effectiveness of the currently available drugs
for a fungus that grows at very low temperatures; these drugs are
usually effective at the physiological range. An equally challenging
task will be the delivery of drugs to an infected population in the
wild. Recent studies on the precipitous decline in amphibians due
to infection by the chytrid fungus Batrachochytrium dendrobatidis have
revealed some important insights including the need for the
judicious selection of a therapeutic agent [4]. Treatment attempts
directed at tadpoles have shown that itraconazole was effective
against the fungus, but it caused severe damage to the host [5].
Conversely, the same treatment worked well in a majority of
anuran species [6]. Other recent studies revealed that the
treatment of fungal infections in amphibians would be best
targeted by selecting drugs that function first in the laboratory
[7,8].
The natural habitat of Gd is unknown although caves are
obviously high on the list because it is believed that hibernating
bats become infected in caves that contain Gd. Caves harbor
unique fungal communities, which are greatly affected by human
activity [9,10]. It is not known if human activities played a role in
the initial outbreak and subsequent spread of geomycosis.
However, the United States Fish and Wildlife Service has
temporarily blocked public access to many caves and mines as a
preventative measure aimed at stopping further spread of the
disease by humans (http://www.fws.gov/whitenosesyndrome/
pdf/NWRS_WNS_Guidance_Final1.pdf). Many of the affected
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might become necessary to decontaminate heavily infested caves
and other natural sites using safe and effective chemicals that
selectively eradicate Gd. This study aimed to identify antifungal
drugs and antiseptic compounds for potential treatment of
geomycosis and decontamination of Gd.
Results
All five strains of Gd had similar antifungal susceptibility profiles in
our tests irrespective of the test devices used (Figure 1A–1C).
Amphotericin B and four azoles (itraconazole, ketoconazole,
posaconazole and voriconazole) were effective at low MICs against
Gd s t r a i n sw h i l ef l u c o n a z o l eM I C sw e r es u g g e s t i v eo fS u s c e p t i b l e -
Dose Dependent (S-DD) pattern. Flucytosine and all three
echinocandins (caspofungin, anidulafungin and micafungin) exhibit-
ed relatively high MICs suggestive of resistance (Figure 1C). Unlike
pathogenic fungi, susceptibility testing of Gd strains required
prolonged incubations for 10–21 days at 15uCa n d6 uC, respectively.
The antifungal susceptibility testing proceeded relatively faster at
15uCt h a na t6 uC as expected due to the better growth of the fungus
seen at 15uC [2]. It is noteworthy that YeastOneH microdilution test
yielded results on an average of 14 days while Etest was positive in 10
days. This difference in turnaround time was accentuated when the
tests were done at 6uC (Figure S1).
The results of HTS identified 27 compounds (1.4% of 1,920
tested), which caused 50% to- greater than 90% inhibition of Gd
growth at 15uC while other compounds tested had no inhibitory
effect (Figure 2A, 2B and Table S1). Of the 27 compounds, ten
were randomly selected for further analysis using 10 mM original
concentration and ten-fold (1.0 mM) and hundred-fold (0.1 mM)
lower concentrations in the microtiter plates. These compounds
and Gd were incubated both at 15uC and 6uC. This secondary
screen confirmed excellent growth inhibitory profiles of selected
compounds at both temperatures (Figure 3 and Tables 1, S2, S3).
Not surprisingly, antifungals (econazole, sulconazole, chloroace-
toxyquinoline, pyrithione zinc, ciclopirox olamine, and chlorox-
ine), fungicide (phenylmercuric acetate), and biocide (benzalk-
onium chloride) caused prominent growth inhibition. Notably,
pyrimidine analog (fluorouracil) and a biomembrane disruptor
(digitonin) were also highly effective.
Discussion
A remarkable observation in this study is that the antifungal
drugs are active at the psychrophilic range, a fact not previously
Figure 1. Antifungal susceptibility testing of Geomyces destructans. Panel A shows an Etest plate incubated for 10 days at 15uC with the
following patterns clockwise from top: amphotericin B (low MIC suggestive of susceptibility) , voriconazole (low MIC suggestive of susceptibility),
caspofungin (high MIC suggestive of resistance), and posaconazole (low MIC suggestive of susceptibility). Panel B includes a representative
YeastOneH plate with magenta microwells showing fungal growth and blue microwells showing growth inhibition. Panel C includes a summary of
results obtained from two devices with susceptibility to amphotericin B, fluconazole, ketoconazole, itraconazole, posaconazole and voriconazole.
Suggestive resistance to flucytosine and caspofungin was found in testing using E-test and YeastOneH, and suggestive resistance to anidulafungin
and micafungin was found in testing using YeastOneH.
doi:10.1371/journal.pone.0017032.g001
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susceptible to amphotericin B and azoles at MICs that are similar
to the values reported for pathogenic yeasts and filamentous fungi
[11,12,13]. Azoles and amphotericin B represent some of the most
effective antifungal drugs that act by inhibition of ergosterol
biosynthesis or by binding to ergosterol in the plasma membrane.
Our results expand their broad-spectrum of activity to a
psychrophilic pathogen. Thus, we have identified many antifungal
drugs that work well in the laboratory against Gd at temperature
ranges likely to be encountered in bat hibernacula. This
observation could be the basis for future trials of these drugs in
efforts aimed at the rehabilitation of most affected bat species.
The observed high flucytosine MIC for Gd was suggestive of
resistance. Such resistance to flucytosine is fairly widespread
among filamentous fungi and the resistance mechanisms are
manifold. In studies with Aspergillus species, it was found that
resistant strains were not defective in the drug uptake nor in its
conversion to 5-flourouracil, but they utilized cytosine as a
nitrogen source to circumvent the drug effect [14]. Another
noteworthy finding of the present study is the high echinocandins
MICs for Gd; this suggests intrinsic resistance similar to other
filamentous pathogens such as Fusarium species, Scedosporium
prolificans, and zygomycetes [13,15]. This finding suggests that Gd
shares an important characteristic with fungal pathogens, which
cause serious and intractable infections in humans. Echinocandins-
resistance in the aforementioned fungi is due to specific mutations
in the membrane protein Fks1, which encodes b-1,3-glucan
synthase catalytic subunit crucial for cell wall synthesis [16]. It
would be interesting to investigate if a similar or a novel
mechanism of echinocandins-resistance exists in Gd.
The yield of effective compounds in HTS relative to the number
of compounds tested is similar to other HTS for antifungal
activities [17,18]. We believe that the psychrophilic conditions
needed for this screen and the innate ability of Gd to grow in the
presence of a diverse group of chemicals limited the outcome to a
few well-known fungal inhibitors. The list of the most effective
compounds included antifungals, fungicide and biocides. In
contrast to these known inhibitors, the high susceptibility of Gd
to fluorouracil was notable and unexpected since Gd was found to
be resistant to flucytosine. This observation suggested that the
Figure 2. High Throughput Screening (HTS) of the compound library for G. destructans growth inhibition. Panel A illustrates a 96-well
microplate used in HTS with growth inhibitions seen at position D10 (benzalkonium chloride-86%), F6 (chloroacetoxyquinoline-87%) and H5
(methylbenzethonium chloride- 91%) compared to the growth controls in columns 1 and 12. Panel B provides an overview of the entire screen of
1,920 compounds with a majority of compounds having no inhibitory effect on the growth of G. destructans.
doi:10.1371/journal.pone.0017032.g002
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and DNA synthesis similar to the dual mode of actions reported
for other fungi [14,19,20]. By the same logic, it is more likely that
the observed flucytosine-resistance in Gd involves either defects in
the uptake of this drug or its inefficient conversion to 5-fluorouracil
(5-FU) and 5-fluorodeoxyuridine monophosphate (5-Fd-UMP).
The effective biocides and fungicides identified in this study are
currently in use, and therefore, could potentially be useful for the
decontamination of Gd infested sites. This is a positive step as
earlier publications on decontamination of sites harboring
pathogenic fungi such as Histoplasma capsulatum used formalin,
which is not an option at present due to the associated toxicity
[21]. However, any proposal for the decontamination of infested
sites requires a careful balance considering the likely deleterious
effects on the environment. It is worth repeating that caves support
a rich diversity of life including many species of fungi and bacteria
[10,22]. So far, extensive published data is only available for
benzalkonium chloride. This chemical was found to be an effective
disinfectant for household items contaminated with the dermato-
phytic pathogen Microsporum canis [23]. Benzalkonium chloride has
been used for many years in the famous Lascaux cave (Montignac,
France) to control Fusarium solani infestation. Although effective,
this treatment has resulted in the replacement of native bacterial
communities with more resistant bacteria [24]. The long-term
environmental effects of such biocide-induced changes remain
unknown. The effective inhibition of Gd growth by phenylmercury
acetate suggests that organomercury fungicides could also be
effective agents for the decontamination of natural sites. Similar to
the concerns with biocides, any future remedial plans involving
fungicides would require further refinements to ensure that the
non-target fungi and other living forms are not harmed [25,26]. In
conclusion, a number of antifungal drugs and inhibitory
compounds were systematically identified in this study; these
results could serve as a starting point for the selection of
appropriate agents to treat Gd-infected bats in rehabilitation
centers and to decontaminate heavily infested sites.
Materials and Methods
Antifungal susceptibility testing
Two different commercial devices were used for antifungal
testing. These devices yield reproducible results and are reported to
be good alternatives to standard methods, which might be too
cumbersome for many laboratories working with Gd [12,27,28,29].
Five strains of Gd characterized in an earlier study were used in the
susceptibility tests [2]. In brief, Gd strains were grown on potato
dextrose agar for 10 days at 15uC. Spore suspensions were prepared
in sterile water, adjusted to OD530=0.1. For testing with Etest
strips, diluted spore suspension was streaked on to RPMI/MOPS
agar and the Etest strips were placed per the manufacturer’s
instruction (bioMerieux, Inc., Durham, NC). For 96-microwell
dilution tests, the YeastOneH with Anidulafungin, Caspofungin and
Micafungin panels were used (Part #YO-9, TREK Diagnostic
Systems, Inc., Cleveland, OH). The susceptibility patterns of
antifungals were assessed 10–14 days post-incubation at 15uCa n d
21–28 days post-incubation at 6uC. We have previously reported
that Gd grows faster at 15uC than at 6uC without any apparent
changes in its morphology or secretory enzymes [2].
High-throughput screening (HTS)
The method used for HTS was done as previously described by
Li et al. [30]. A SpectrumPlus (MicroSource) library representing
Figure 3. Summary of secondary screening for G. destructans growth inhibition. The results shown were obtained at 15uC and 6uC with 10
promising compounds tested ten-fold and hundred-fold lower concentrations than used in the initial screen. Note that two topical azole antifungals
and a fungicide were most effective at all concentrations tested. (Abbreviation: ECO econazole nitrate, SCO sulconazole nitrate, PMA phenylmercuric
acetate, CAQ chloroacetoxyquinoline, 5-FU fluorouracil, ZnP pyrithione zinc, CPX ciclopirox olamine, DIG digitonin, CHL chloroxine, BZCL
benzalkonium chloride).
doi:10.1371/journal.pone.0017032.g003
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experimental actives, and pure natural products, was used. The
compounds were distributed in sterile 96-microwell plates with a
Sciclone ALH 3000 workstation (Caliper Life Sciences, Hopkin-
ton, MA). The control well of the 96-microwell plate contained
100 ml of 0.1% DMSO in sterile water+100 mlo fGd spore
suspension (OD530=0.1) in 26yeast nitrogen glucose broth (2%
yeast nitrogen base+4% glucose; YNGB). All other wells contained
100 ml of different drugs (10 mM concentration in 0.1%
DMSO)+100 ml of spore suspension in 26 YNGB. The growth
inhibition was assessed spectrophotometrically after 10 days of
incubation at 15uC. Inhibition of the compounds was calculated as
percentages from the ratio of absorbance for Gd with compound
wells compared to no compound in 0.1% DMSO alone.
Secondary screening of selected compounds proceeded similar to
the primary screen except that the 10- and 100-fold lower
concentrations of the effective compounds identified in the initial
screens were tested both at 15uC and 6uC.
Supporting Information
Figure S1 Antifungal susceptibility testing of Geomyces
destructans. Panel A. Etest plate showing G. destructans
antifungal susceptibility and resistance at 6uC incubated for 21
days with the following susceptibility patterns, clockwise from top:
amphotericin B (susceptible), voriconazole (susceptible), caspofun-
gin (resistant) and posaconazole (susceptible). Panel B. YeastOneH
plate with magenta microwells showing G. destructans growth and
blue microwells with growth inhibition at 6uC. Well A1 is positive
control, A2–A11 anidulafungin, B1–B11 micafungin, C1–C11
caspofungin, D1–D11 flucytosine, E1–11 posaconazole, F1–F11
voriconazole, G1–G11 itraconazole, H1–H12 fluconazole and
Column 12, Row A–G amphotericin B.
(DOCX)
Table S1 Results of high throughput screen (HTS) of
1920 compounds in SpectrumPlus Library for growth
inhibition of Geomyces destructans.
(XLSX)
Table S2 Results of secondary screen of Geomyces
destructans against 10 selected compounds at 156C.
(XLSX)
Table S3 Results of secondary screen of Geomyces
destructans against 10 selected compounds at 66C.
(XLSX)
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Table 1. List of compounds from SpectrumPlus Compound Library found highly effective at growth inhibition of Geomyces
destructans at 6uC and 15uC.
# Compounds Abbreviation Chemical Description Mode of action
1 Econazole nitrate ECO Imidazole class Inhibition of 14 ,alpha.-sterol
demethylase and the
subsequent blockage of ergosterol
biosynthesis; antifungal
drug for Athlete’s foot, ringworm, etc.
2 Sulconazole nitrate SCO Imidazole class Inhibition of 14 ,alpha.-sterol
demethylase and the subsequent
blockage of ergosterol biosynthesis;
antifungal drug for treatment
of Athlete’s foot, ringworm, etc.
3 Phenylmercuric acetate PMA Organomercury compound Fungicide
4 Chloroacetoxyquinoline CAQ Hydroxyquinoline derivative Antibacterial, antifungal
5 Fluorouracil 5-FU Pyrimidine analog (heterocyclic
aromatic compound)
Noncompetitive inhibition of thymidylate
synthase; synthesis of
aberrant mRNA and the subsequent
inhibition of protein synthesis;
cancer drug
6 Pyrithione Zinc ZnP Coordination complex of Zinc Antifungal & antibacterial agent
7 Ciclopirox olamine CPX Synthetic compound (6-cyclohexyl-1-
hydroxy-4-methylpyridin-2(1H)-one)
Topical antifungal for superficial mycoses
8 Digitonin DIG Glycoside (from Digitalis purpurea) Detergent, Biomembrane disruptor
9 Chloroxine CHL Halogenated hydroxyquinoline Antibacterial, Antifungal
10 Benzalkonium chloride BZCL Quaternary ammonium group Antiseptic, biocide, surfactant,
doi:10.1371/journal.pone.0017032.t001
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